{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:37:39Z","timestamp":1785469059112,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Cure for Cancer","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02678-9","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T10:47:51Z","timestamp":1750502871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of chemoradiotherapy for bladder cancer on pre-existing hydronephrosis and development of new hydronephrosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Marinka J.","family":"Remmelink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader el","family":"Awadly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berber","family":"Arbeel-Weening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Nadorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maicle R.","family":"Leter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorg R.","family":"Oddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Br\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakko A.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan D.","family":"Bins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"issue":"1","key":"2678_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21037\/tau.2018.09.11","volume":"8","author":"MGK Cumberbatch","year":"2019","unstructured":"Cumberbatch MGK, Noon AP. Epidemiology, aetiology and screening of bladder cancer. Transl Androl Urol. 2019;8(1):5\u201311. https:\/\/doi.org\/10.21037\/tau.2018.09.11.","journal-title":"Transl Androl Urol"},{"issue":"1","key":"2678_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"AJ Witjes","year":"2024","unstructured":"Witjes AJ, Bruins MH, Carri\u00f3n A, Cathomas R, Comp\u00e9rat E, Efstathiou JA, et al. European association of urology guidelines on Muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines. Eur Urol. 2024;85(1):17\u201331. https:\/\/doi.org\/10.1016\/j.eururo.2023.08.016.","journal-title":"Eur Urol"},{"issue":"1","key":"2678_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/jso.2930520109","volume":"52","author":"I Leibovitch","year":"1993","unstructured":"Leibovitch I, Ben-Chaim J, Ramon J, Madjar I, Engelberg IS, Goldwasser B. The significance of ureteral obstruction in invasive transitional cell carcinoma of the urinary bladder. J Surg Oncol. 1993;52(1):31\u20135. https:\/\/doi.org\/10.1002\/jso.2930520109.","journal-title":"J Surg Oncol"},{"issue":"2","key":"2678_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/s0022-5347(17)60993-5","volume":"107","author":"WT Bowles","year":"1972","unstructured":"Bowles WT, Silber I. Carcinoma of the bladder: a computer analysis of 516 patients. J Urol. 1972;107(2):245\u20137. https:\/\/doi.org\/10.1016\/s0022-5347(17)60993-5.","journal-title":"J Urol"},{"issue":"5","key":"2678_CR5","first-page":"305","volume":"46","author":"J Asadauskiene","year":"2010","unstructured":"Asadauskiene J, Aleknavicius E, Pipiriene-Zelviene T, Jankevicius F. The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer. Med (Kaunas). 2010;46(5):305\u201314.","journal-title":"Med (Kaunas)"},{"key":"2678_CR6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fonc.2019.00158","volume":"9","author":"JJ Oh","year":"2019","unstructured":"Oh JJ, Byun SS, Jeong CW, Kwak C, Kim HH, Ku JH. Association between preoperative hydronephrosis and prognosis after radical cystectomy among patients with bladder cancer: A systemic review and Meta-Analysis. Front Oncol. 2019;9:158. https:\/\/doi.org\/10.3389\/fonc.2019.00158.","journal-title":"Front Oncol"},{"issue":"6","key":"2678_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","volume":"24","author":"AR Zlotta","year":"2023","unstructured":"Zlotta AR, Ballas LK, Niemierko A, Lajkosz K, Kuk C, Miranda G, et al. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. Lancet Oncol. 2023;24(6):669\u201381. https:\/\/doi.org\/10.1016\/S1470-2045(23)00170-5.","journal-title":"Lancet Oncol"},{"issue":"19","key":"2678_CR8","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. Chronic kidney disease epidemiology collaboration. New Creatinine- and Cystatin C-Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349. https:\/\/doi.org\/10.1056\/NEJMoa2102953.","journal-title":"N Engl J Med"},{"issue":"4","key":"2678_CR9","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u201384. https:\/\/doi.org\/10.1159\/000339789.","journal-title":"Nephron Clin Pract"},{"key":"2678_CR10","volume-title":"TNM classification of malignant tumors","author":"JD Brierley","year":"2016","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. 8th ed. Oxford: Wiley-Blackwell; 2016.","edition":"8"},{"issue":"4S","key":"2678_CR11","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"issue":"13","key":"2678_CR12","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.3390\/jcm12134371","volume":"12","author":"D Baracaldo-Santamar\u00eda","year":"2023","unstructured":"Baracaldo-Santamar\u00eda D, Feliciano-Alfonso JE, Ramirez-Grueso R, Rojas-Rodr\u00edguez LC, Dominguez-Dominguez CA, Calderon-Ospina CA. Making sense of composite endpoints in clinical research. J Clin Med. 2023;12(13):4371. https:\/\/doi.org\/10.3390\/jcm12134371.","journal-title":"J Clin Med"},{"issue":"6","key":"2678_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"2678_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/jjco\/hyp023","volume":"39","author":"K Hashine","year":"2009","unstructured":"Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y, Kataoka M. Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer. Jpn J Clin Oncol. 2009;39(6):381\u20136. https:\/\/doi.org\/10.1093\/jjco\/hyp023.","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"2678_CR15","doi-asserted-by":"publisher","first-page":"100718","DOI":"10.1016\/j.adro.2021.100718","volume":"6","author":"P Polineni","year":"2021","unstructured":"Polineni P, Ashack L, Kalapurakal J, Morgans A, VanderWeele D, Kundu S, et al. Trimodality treatment for Muscle-Invasive bladder cancer: an institutional experience. Adv Radiat Oncol. 2021;6(5):100718. https:\/\/doi.org\/10.1016\/j.adro.2021.100718.","journal-title":"Adv Radiat Oncol"},{"issue":"9","key":"2678_CR16","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jfma.2016.10.014","volume":"116","author":"Y Chiang","year":"2017","unstructured":"Chiang Y, Cheng JC, Huang CY, Tsai YC, Lin CC, Hsu CH, et al. A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement. J Formos Med Assoc. 2017;116(9):689\u201396. https:\/\/doi.org\/10.1016\/j.jfma.2016.10.014.","journal-title":"J Formos Med Assoc"},{"issue":"7","key":"2678_CR17","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1023\/a:1011133820532","volume":"12","author":"SA Hussain","year":"2001","unstructured":"Hussain SA, Moffitt DD, Glaholm JG, Peake D, Wallace DM, James ND. A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer. Ann Oncol. 2001;12(7):929\u201335. https:\/\/doi.org\/10.1023\/a:1011133820532.","journal-title":"Ann Oncol"},{"issue":"3","key":"2678_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.juro.2013.09.011","volume":"191","author":"MS Eisenberg","year":"2014","unstructured":"Eisenberg MS, Thompson RH, Frank I, Kim SP, Cotter KJ, Tollefson MK, et al. Long-term renal function outcomes after radical cystectomy. J Urol. 2014;191(3):619\u201325. https:\/\/doi.org\/10.1016\/j.juro.2013.09.011.","journal-title":"J Urol"},{"issue":"9","key":"2678_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/iju.14970","volume":"29","author":"T Tanaka","year":"2022","unstructured":"Tanaka T, Shindo T, Hashimoto K, Kobayashi K, Masumori N. Management of hydronephrosis after radical cystectomy and urinary diversion for bladder cancer: A single tertiary center experience. Int J Urol. 2022;29(9):1046\u201353. https:\/\/doi.org\/10.1111\/iju.14970.","journal-title":"Int J Urol"},{"issue":"4","key":"2678_CR20","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/JU.0000000000001518","volume":"205","author":"DJ Reesink","year":"2021","unstructured":"Reesink DJ, Gerritsen SL, Kelder H, van Melick HHE, Stijns PEF. Evaluation of ureteroenteric anastomotic strictures after the introduction of Robot-Assisted radical cystectomy with intracorporeal urinary diversion: results from a large tertiary referral center. J Urol. 2021;205(4):1119\u201325. https:\/\/doi.org\/10.1097\/JU.0000000000001518.","journal-title":"J Urol"},{"issue":"2","key":"2678_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.juro.2012.09.034","volume":"189","author":"CB Anderson","year":"2013","unstructured":"Anderson CB, Morgan TM, Kappa S, Moore D, Clark PE, Davis R, et al. Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? J Urol. 2013;189(2):541\u20137. https:\/\/doi.org\/10.1016\/j.juro.2012.09.034.","journal-title":"J Urol"},{"issue":"3","key":"2678_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.juro.2013.10.022","volume":"191","author":"M Nazmy","year":"2014","unstructured":"Nazmy M, Yuh B, Kawachi M, Lau CS, Linehan J, Ruel NH, et al. Early and late complications of robot-assisted radical cystectomy: a standardized analysis by urinary diversion type. J Urol. 2014;191(3):681\u20137. https:\/\/doi.org\/10.1016\/j.juro.2013.10.022.","journal-title":"J Urol"},{"issue":"2","key":"2678_CR23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.juro.2010.09.096","volume":"185","author":"MS Shimko","year":"2011","unstructured":"Shimko MS, Tollefson MK, Umbreit EC, Farmer SA, Blute ML, Frank I. Long-term complications of conduit urinary diversion. J Urol. 2011;185(2):562\u20137. https:\/\/doi.org\/10.1016\/j.juro.2010.09.096.","journal-title":"J Urol"},{"key":"2678_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.urology.2018.06.024","volume":"144","author":"KA Amin","year":"2020","unstructured":"Amin KA, Vertosick EA, Stearns G, Fathollahi A, Sjoberg DD, Donat MS, et al. Predictors of benign ureteroenteric anastomotic strictures after radical cystectomy and urinary diversion. Urology. 2020;144:225\u20139. https:\/\/doi.org\/10.1016\/j.urology.2018.06.024.","journal-title":"Urology"},{"key":"2678_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.urology.2019.07.054","volume":"135","author":"AC Goh","year":"2020","unstructured":"Goh AC, Belarmino A, Patel NA, Sun T, Sedrakyan A, Bochner BH, et al. A Population-based study of ureteroenteric strictures after open and Robot-assisted radical cystectomy. Urology. 2020;135:57\u201365. https:\/\/doi.org\/10.1016\/j.urology.2019.07.054.","journal-title":"Urology"},{"issue":"3","key":"2678_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006;49(3):466\u20135. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.031.","journal-title":"Eur Urol"},{"issue":"11","key":"2678_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.urolonc.2020.06.034","volume":"38","author":"KH Tully","year":"2020","unstructured":"Tully KH, Moschini M, von Rundstedt FE, Aziz A, Kluth LA, Necchi A, et al. Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size. Urol Oncol. 2020;38(11):851. https:\/\/doi.org\/10.1016\/j.urolonc.2020.06.034.","journal-title":"Urol Oncol"},{"issue":"2","key":"2678_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3233\/BLC-200273","volume":"6","author":"J Loloi","year":"2020","unstructured":"Loloi J, Allen JL, Schilling A, Hollenbeak C, Merrill SB, Kaag MG, et al. In the world of bladder tumors: size does matter. IOS Press. 2020;6(2):195\u2013200. https:\/\/doi.org\/10.3233\/BLC-200273.","journal-title":"IOS Press"},{"issue":"2","key":"2678_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1053\/j.ajkd.2019.12.010","volume":"76","author":"M Zhan","year":"2020","unstructured":"Zhan M, Doerfler RM, Xie D, Chen J, Chen HY, Diamantidis CJ, et al. Association of opioids and nonsteroidal Anti-inflammatory drugs with outcomes in CKD: findings from the CRIC (Chronic renal insufficiency Cohort) study. Am J Kidney Dis. 2020;76(2):184\u201393. https:\/\/doi.org\/10.1053\/j.ajkd.2019.12.010.","journal-title":"Am J Kidney Dis"}],"updated-by":[{"DOI":"10.1186\/s13014-025-02729-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000}}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02678-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02678-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02678-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T04:09:53Z","timestamp":1767931793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-025-02678-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02678-9","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13014-025-02729-1","URL":"https:\/\/doi.org\/10.1186\/s13014-025-02729-1","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional ethics board approval was waived by the medical ethical committee of Amsterdam Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}